Neurocognitive consequences of diabetes

Area of Science:

• Neuroscience
• Endocrinology
• Psychology

Background:

• Mild cognitive dysfunction is a known complication of diabetes, yet often overlooked by healthcare professionals.
• Understanding its etiology and clinical implications is crucial for effective patient management.

Purpose of the Study:

• To delineate neurocognitive phenotypes in Type 1 (T1D) and Type 2 diabetes (T2D).
• To identify modifiable and non-modifiable risk factors for cognitive dysfunction in diabetes.
• To highlight the role of psychologists and behavioral scientists in prevention and management.

Main Methods:

• Review of key studies, systematic reviews, and meta-analyses on diabetes and cognitive function.
• Analysis of neurocognitive phenotypes in T1D and T2D.
• Identification of risk factors including metabolic control and age of diagnosis.

Main Results:

• T1D is associated with lower scores in intelligence, academic achievement, attention, psychomotor speed, and executive functions, particularly when diagnosed early.
• Elevated blood glucose correlates with cognitive dysfunction and white matter changes.
• T2D involves deficits in attention, psychomotor speed, executive functions, learning, and memory, increasing dementia risk.
• Poorer metabolic control accelerates cognitive decline; improved control may slow it.

Conclusions:

• Diabetes significantly impacts cognitive function, with distinct patterns in T1D and T2D.
• Metabolic control is a critical modifiable factor influencing cognitive decline.
• Behavioral interventions can improve adherence and metabolic control, mitigating cognitive complications.